Welcome to HealthCareMEA.com
LATEST AFRICAN & MIDDLE EAST NEWS
Pathologists Lancet Kenya rebrands as Cerba Lancet Kenya, focuses on enhanced patient care
Mar 19, 2024
KENYA—Pathologists Lancet Kenya, a renowned diagnostic provider in the country, has successfully...
Read MoreSAMRC partners with Thermo Fisher to launch the Centre of Excellence for molecular biology training
Mar 19, 2024
SOUTH AFRICA—The South African Medical Research Council (SAMRC) and Thermo Fisher Scientific Inc.,...
Read MoreKenya’s Pharmacy and Poisons Board strengthens medical device regulation with US FDA collaboration
Mar 18, 2024
USA—The Pharmacy and Poisons Board (PPB) has achieved a significant milestone in regulatory...
Read MoreKenya boosts healthcare workforce with REACH Program launch
Mar 18, 2024
KENYA—Kenya has launched the Resilient and Empowered African Community Health (REACH) program in...
Read MoreKHF warns of NHIF payment delays and calls for urgent reforms
Mar 17, 2024
KENYA—The Kenya Healthcare Federation (KHF), a Health Sector Board of the Kenya Private Sector...
Read More>>> MORE AFRICAN & MIDDLE EAST NEWS
LATEST WORLD NEWS
FDA approves first drug for advanced MASH, Rezdiffra
Mar 18, 2024
USA—Rezdiffra has been approved by the Food and Drug Administration, marking a significant...
>>> MORE WORLD NEWS
HOSPITALS NEWS
Pathologists Lancet Kenya rebrands as Cerba Lancet Kenya, focuses on enhanced patient care
Mar 19, 2024
KENYA—Pathologists Lancet Kenya, a renowned diagnostic provider in the country, has successfully...
MEDICAL DEVICES & INNOVATIONS
Mayo Clinic Platform unveils Solutions Studio to expedite digital health innovation
Mar 17, 2024
USA—Mayo Clinic, a nonprofit American academic medical center dedicated to integrated healthcare,...
-
-
-
-
Siemens launches interactive anatomy app
Mar 7, 2024
PHARMACEUTICALS & MANUFACTURING NEWS
FDA approves Breyanzi, a New CAR-T Cell Therapy for blood cancers
Mar 18, 2024
USA—The Food and Drug Administration of the United States has approved Breyanzi, a cell therapy...
-
FDA approves first drug for advanced MASH, Rezdiffra
Mar 18, 2024
-
-
-